The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trifluridine/tipiracil plus capecitabine and bevacizumab as upfront treatment for metastatic colorectal cancer: Results of the phase 1 TriComB study.
 
Paolo Ciracì
No Relationships to Disclose
 
Veronica Conca
No Relationships to Disclose
 
Roberto Moretto
No Relationships to Disclose
 
Carlotta Antoniotti
Honoraria - Merck
Travel, Accommodations, Expenses - Merck
 
Margherita Ambrosini
No Relationships to Disclose
 
Sabina Murgioni
No Relationships to Disclose
 
Giovanni Gori
No Relationships to Disclose
 
Alessandra Russo
No Relationships to Disclose
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Pierre Fabre; SERVIER
Speakers' Bureau - Bayer; BMS; Eisai; Lilly; MSD Oncology
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis
 
Giovanni Randon
No Relationships to Disclose
 
Vittorio Studiale
No Relationships to Disclose
 
Elisabetta Fini
No Relationships to Disclose
 
Federica Marmorino
No Relationships to Disclose
 
Beatrice Borelli
No Relationships to Disclose
 
Marco Maria Germani
No Relationships to Disclose
 
Guglielmo Vetere
No Relationships to Disclose
 
Martina Carullo
No Relationships to Disclose
 
Chiara Boccaccio
No Relationships to Disclose
 
Gianluca Masi
Consulting or Advisory Role - AstraZeneca; Eisai; MSD Oncology; Roche; Roche
Research Funding - Terumo (Inst); Terumo (Inst)
Patents, Royalties, Other Intellectual Property - Terumo (Inst)
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Nordic Bioscience; Pierre Fabre; Roche
Speakers' Bureau - Merck; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER